Verrica Pharmaceuticals

$13.76
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.19 (-1.36%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell VRCA and other stocks, options, and ETFs commission-free!

About VRCA

Verrica Pharmaceuticals, Inc. engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its lead product candidate VP-102, is a proprietary topical therapy used in common skin indications including molluscum contagiosum and verruca vulgaris.

CEO
Ted White
Employees
29
Headquarters
West Chester, Pennsylvania
Founded
2013
Market Cap
383.21M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
135.61K
High Today
$14.07
Low Today
$13.62
Open Price
$13.92
Volume
60.31K
52 Week High
$18.42
52 Week Low
$8.83

VRCA Earnings

-$0.52
-$0.35
-$0.17
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 4, Pre-Market

You May Also Like

IRR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure